Product Images Banzel

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 17 images provide visual information about the product associated with Banzel NDC 62856-584 by Eisai Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

BANZEL (rufinamide) - banzel 01

BANZEL (rufinamide) - banzel 01

Tablet Imprint - banzel 02

Tablet Imprint - banzel 02

Figure A - banzel 03

Figure A - banzel 03

Figure B - banzel 04

Figure B - banzel 04

Figure C - banzel 05

Figure C - banzel 05

The text is readable but it is too short to provide a useful description. It simply states "bottle adapter".*

Figure D - banzel 06

Figure D - banzel 06

Figure E - banzel 07

Figure E - banzel 07

Figure F - banzel 08

Figure F - banzel 08

Figure G - banzel 09

Figure G - banzel 09

Figure H - banzel 0a

Figure H - banzel 0a

Figure I - banzel 0b

Figure I - banzel 0b

Figure J - banzel 0c

Figure J - banzel 0c

Figure K - banzel 0d

Figure K - banzel 0d

PRINCIPAL DISPLAY PANELNDC 62856-582-04BANZEL® (rufinamide) TABLETS200 mg4 tablets - banzel 0e

PRINCIPAL DISPLAY PANELNDC 62856-582-04BANZEL® (rufinamide) TABLETS200 mg4 tablets - banzel 0e

Store BANZEL medication at room temperature of 25°C (77°F) and ensure it is protected from moisture. The medication should not be exposed to temperatures below 15°C (GO°F) or above 30°C (86°F). After opening, replace the cap securely. Detailed instructions on its dosage and use can be found in the accompanying prescribing information. This is a prescription-only medication, and the medication guide provided must be dispensed with the bottle. The given batch comprises 120 tablets of 200 mg of rufinamide. The lot number, expiration date, and serialization area are also provided.*

PRINCIPAL DISPLAY PANELNDC 62856-582-52BANZEL® (rufinamide) TABLETS200 mg120 tablets - banzel 0f

PRINCIPAL DISPLAY PANELNDC 62856-582-52BANZEL® (rufinamide) TABLETS200 mg120 tablets - banzel 0f

This is a label for BANZEL tablets, containing 400mg rufinamide each. It indicates that the tablets should be stored at a temperature between 15°C-30°C (69°F-86°F), protected from moisture, and the cap should be replaced after opening. There is some dosage and use information, which should be reviewed with the accompanying prescribing information. The label includes a lot number, expiration date, and serialization area. It also notes that the medication guide provided with the bottle should be dispensed.*

PRINCIPAL DISPLAY PANELNDC 62856-583-14BANZEL®(rufinamide) TABLETS400 mg14 tablets - banzel 10

PRINCIPAL DISPLAY PANELNDC 62856-583-14BANZEL®(rufinamide) TABLETS400 mg14 tablets - banzel 10

This is a description of Banzel, an oral suspension medication used for treatment purposes. It contains rufinamide and a concentration of 40mg/mL. The medication should be shaken before use, stored at room temperature, and should be discarded within 90 days after opening. The prescription information for dosage and use should be consulted.*

PRINCIPAL DISPLAY PANELNDC 62856-583-52BANZEL®(rufinamide) TABLETS400 mg120 tablets - banzel 11

PRINCIPAL DISPLAY PANELNDC 62856-583-52BANZEL®(rufinamide) TABLETS400 mg120 tablets - banzel 11

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.